The RIALTO™ SI Fusion System consists of cannulated devices of various widths and lengths used to provide stabilization when fusion of the sacroiliac joint is desired. Autograft and/or allograft may be placed in conjunction with the RIALTO™ SI Fusion System. This device may be implanted via a minimally invasive approach.
The RialtoTM SI Fusion System is intended to stabilize your sacroiliac joint and provide an environment for fusion (joining bones together into one solid structure) to occur.The Rialto SI fusion system consists of cylindrical threaded devices designed to enhance sacroiliac joint fusion. The threaded devices are offered in various lengths to accommodate your anatomy. For fusion of the SI joint, one, two, or three devices may be placed at your surgeon’s discretion.The RIALTO™ SI Fusion System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.
Benefits:
- Physicians can use a minimally invasive approach through a small incision.
- Insertion of the device causes minimal tissue disruption.
- Bone graft can be delivered within the device to promote a fusion.
About Medtronic
Medtronic plc headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 88,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.(www.medtronic.com)